Advantix Spot-on Solution for Dogs over 40 kg up to 60 kg

Land: Verenigd Koninkrijk

Taal: Engels

Bron: VMD (Veterinary Medicines Directorate)

Werkstoffen:

Imidacloprid, Permethrin (Cis:Trans 40:60)

Beschikbaar vanaf:

Bayer plc

ATC-code:

QP53AC54

INN (Algemene Internationale Benaming):

Imidacloprid, Permethrin (Cis:Trans 40:60)

farmaceutische vorm:

Spot-on solution

Prescription-type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutische categorie:

Dogs

Therapeutisch gebied:

Ectoparasiticide

Autorisatie-status:

Authorized

Autorisatie datum:

2017-11-28

Productkenmerken

Revised: February 2021
AN: 01798/2019
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantix Spot-on solution for dogs over 40 kg up to 60 kg
[AT, CZ, DE, EL, HU,
IE, IT, NL, PT, SK, ES, UK]
ADVANTIX TRES GRAND CHIEN [FR]
Bayvantic vet spot-on solution for dogs over 40 kg up to 60 kg
[DK, FI, NO]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 6.0 ml contains:
ACTIVE SUBSTANCES:
Imidacloprid:
600.0 mg
Permethrin (40/60):
3000.0 mg
EXCIPIENT(S):
Butylhydroxytoluene (E321): 6.0 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution
Clear yellowish to brownish solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs (over 40 kg up to 60 kg)
For dogs less than or equal to 40 kg or more than 60 kg body weight,
use the
appropriate Advantix Spot-on solution product or combination of
products (see
section 4.9).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and prevention of flea (_Ctenocephalides canis_,
_Ctenocephalides_
_felis_) infestation.
Fleas on dogs are killed within one day following treatment. One
treatment prevents
further flea infestation for four weeks. The product can be used as
part of a treatment
strategy for flea allergy dermatitis (FAD).
For the treatment of biting lice (_Trichodectes canis_).
Page 1 of 9
Revised: February 2021
AN: 01798/2019
The product has persistent acaricidal and repellent efficacy against
tick infestations
(_Rhipicephalus sanguineus_ and _Ixodes ricinus_ for four weeks, and
_Dermacentor_
_reticulatus_ for three weeks)_._
By repelling and killing the tick vector_ _
_Rhipicephalus sanguineus,_
_ _the product
reduces the likelihood of transmission of the pathogen_ Ehrlichia
canis, _thereby
reducing the risk of_ _ canine ehrlichiosis. The reduction in risk has
been shown in
studies to commence from 3 days following application of the product
and to persist
for 4 weeks.
Ticks already on the dog may not be killed within two days after
treatment and may
remain attached and visible